Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Bortezomib for Injection 2 MG & 3.5 MG (Lyophilized) [BORTESAM]
Connect with this vendor - Learn about this product

Bortezomib for Injection 2 MG & 3.5 MG (Lyophilized) [BORTESAM]

BORTESAM is indicated for the treatment of patients with multiple myeloma and for the treatment of patients with mantle cell lymphoma who has received atleast 1 prior therapy.